Stay updated on Safety & Efficacy of Filgotinib & Lanraplenib in LMN Clinical Trial

Sign up to get notified when there's something new on the Safety & Efficacy of Filgotinib & Lanraplenib in LMN Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Safety & Efficacy of Filgotinib & Lanraplenib in LMN Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    A new Locations section was added listing study sites across Alabama, California, Florida, Georgia, Michigan, and North Carolina. The previous per-state location headings were removed, and the HHS Vulnerability Disclosure link was removed.
    Difference
    0.7%
    Check dated 2025-12-23T20:56:51.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    No Change Detected
  4. Check
    31 days ago
    Change Detected
    Summary
    The Publications section text was updated to clarify that publications are automatically filled from PubMed, with the revision version updated from v3.2.0 to v3.3.2.
    Difference
    0.1%
    Check dated 2025-11-25T10:32:22.000Z thumbnail image
  5. Check
    38 days ago
    Change Detected
    Summary
    The page no longer displays the government funding operating status notice; the study details, locations, and eligibility criteria remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-18T06:51:12.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    Both screenshots present the same study record with no changes to core content, outcomes, or eligibility. Any differences appear to be cosmetic layout or loading artifact rather than substantive edits. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-03T20:51:41.000Z thumbnail image
  7. Check
    81 days ago
    Change Detected
    Summary
    Core content updated: a government funding and operating status notice has been added and the version updated to v3.2.0; the prior v3.1.0 tag was removed.
    Difference
    4%
    Check dated 2025-10-06T05:14:24.000Z thumbnail image
  8. Check
    88 days ago
    Change Detected
    Summary
    Version updated from v3.0.2 to v3.1.0; no other content changes detected.
    Difference
    0.1%
    Check dated 2025-09-29T02:59:46.000Z thumbnail image

Stay in the know with updates to Safety & Efficacy of Filgotinib & Lanraplenib in LMN Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Safety & Efficacy of Filgotinib & Lanraplenib in LMN Clinical Trial page.